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In-vitro assessment of antibiotic combinations
against multidrug resistant gram negative
bacilli in South India: A save carbapenem
campaign
R. Tellis
yenepoya medical college, Mangalore, karnataka,
India
Background: Infections caused by MDR pathogens are a thera-
peutic challenge being resistant to most of the available antibiotics
and carbapenem mono-therapy is often used to treat these infec-
tions. Because resistance to carbapenems is increasing, there is a
need to explore the potential of combination antibiotic therapy.
As clinical data to support the choice of antibiotic combinations
are sparse and conﬂicting, antibiotics in combination regimen are
selectedbasedon intuition andanecdotal reports and this approach
is poorly guided, as the antibiotic combination selected may not
always be optimal, because different combinations may be asso-
ciated with different killing activity against MDR pathogens. This
study aims todetermine in-vitro efﬁcacyof antibiotic combinations
devoid of carbapenems, which will reveal the potential synergy
between two antibiotics belonging to different chemical classes,
especially when resistance to any one of them is present. Out-
come of this study is expected to help in drafting robust in-house
antibiotic policy and ease the pressure off carbepenems which are
currently used overwhelmingly in clinical practice.
Methods&Materials: This is a prospective, experimental study
where antibiogram of 85 MDR-GNB isolated from clinical sam-
ples was analysed. Minimum Inhibitory Concentration (MIC) of
ceftazidime, amikacin, imepenem and ciproﬂoxacin for these bac-
teria was determined by broth micro-dilution according to CLSI
guidelines. In-vitro effect of antibiotic combinations: CAZ- AMK,
CAZ-CIPRO, IMP-AMK and IMP-CIPRO was studied by checker-
board assay.
Results: 62.35%, 27.05% and 44.70% of these MDR-GNB
were ESBL, AmpC and MBL producers respectively. 27.05% co-
produced multiple -lactamases. MIC90 ranges for Ceftazimine
:16- ≥1028g/ml, Amikacin: 0.25 - ≥256g/ml, Ciproﬂoxacin:
0.25-128g/ml and Imepenem: 0.125-512g/ml. CAZ- AMK and
IMP-AMK combinations showed synergistic effect in 80%-90% of
MDR-GNB with FICI value of ≤0.5. Higher rates of indifference (0.5
> FICI ≤2) and antagonism (FICI > 2) were observed with combina-
tions having ﬂuroquinolones.
Conclusion: In-vitro antimicrobial activity of antibiotic com-
binations having 3rd or 4th generation cephalosporin with
aminoglycosides was comparable to that of imepenem mono-
therapy or combination and could be used to trea severe infections
caused by MDR-GNB. Therefore combinations devoid of carbepen-
ems should be advocated to prolong the clinical usefulness of this
antibiotic group.
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Prevalence of plasmid-mediated quinolone
resistance genes among ciproﬂoxacin-resistant
clinical isolates of enterobacteriaceae over four
years: A descriptive study
Y. Thiyagarajan ∗, B. Harish
Jawaharlal I nstitute of Medical Education &
Research (JIPMER), Pondicherry, India
Background: Plasmid-mediated quinolone resistance (PMQR)
has received considerable attention recently. Data analysis in
JIPMER revealed 85% of the Enterobacteriaceae isolates to be
ciproﬂoxacin-resistant in 2012. Few reports regarding the preva-
lence of PMQR are available from India. Hence, the present study
was carried out to ascertain the prevalence of PMQR genes among
ciproﬂoxacin-resistant clinical isolates belonging to family Enter-
obacteriaceae.
Graphical representation of annual ciproﬂoxacin consump-
tion and frequency of PMQR isolates for three years in JIPMER.
Methods&Materials: A total of 790 Enterobacteriaceae clinical
isolates resistant to ciproﬂoxacin bydisk diffusion andagar dilution
were studied. The isolates were screened for PMQR genes, and the
positive isolateswere further tested for the integrons intI1and intI2.
The hospital’s annual consumption data for ﬂuoroquinolones were
retrieved from JIPMER Pharmacy.
Distribution of PMQR genes across the bacterial isolateswith
different MIC values.
Results: Most strains exhibited high MIC values with 18% (150)
showing MICs >256g/mL. Overall, PMQR genes were detected in
525 (66%) isolates with 50 (6%) isolates carrying multiple PMQR
genes. PMQR frequencies were as follows; aac(6’)-Ib-cr 414 (64%),
qnrB 97 (15%), and qnrS 64 (10%). Remarkably, 15 isolates were
found positive for the single mutant variant of aac(6’)-Ib that was
conﬁrmed by sequencing. The nucleotide sequences of the PMQR
genes reported in our study are available in GenBank (KR080534
- KR080546). Variant alleles of PMQR genes were not found based
on the pair-wise distance matrix analysis. None of the strains were
positive for qnrA & qnrD. This study excluded qnrC allele. The fre-
quencies of intI1 and intI2 among the PMQR isolates were 35% and
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15% respectively whereas 7% had both the integrons. Transferabil-
ity of PMQR genes to transconjugantswas conﬁrmed. Interestingly,
neither the ﬂuoroquinolone consumption in the hospital nor the
frequency of PMQR isolates varied much in the four years of the
study.
Conclusion: Only three strains with MIC >256g/mL were
PMQR-negative. The frequency of PMQR genes among the bacte-
rial population studied is higher than reported elsewhere. Notably,
all the ciproﬂoxacin-resistant Escherichia coli carried PMQR genes.
The presence of PMQR gene in Providencia rettgeri has not been
reported before. Finally, this study reports the single mutant vari-
ant of aac(6’)-Ib gene for the ﬁrst time from the clinical isolates. To
conclude there is a need for rational usage of ﬂuoroquinolones and
reconsideration of their clinical breakpoints.
Pair-wise distance matrix analysis of acc(6’)-Ib-cr gene.
http://dx.doi.org/10.1016/j.ijid.2016.02.300
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Towards a national action plan for
antimicrobial resistance: The Kenyan
experience
E. Wesangula ∗, R. Kamau, V. Kamau, F. Kiberenge
Ministry of Health, Nairobi, Kenya
Background: From the situation analysis on Antimicrobial use
and resistance in Kenya 2011, 50% of the leading causes of death
in Kenya are due to infectious diseases and antimicrobial resis-
tance tomicrobes indicated rising trendsof resistance to commonly
used antibiotics (66%, 94%, 53%, 43% to cotrimoxazole, ampicillin,
ﬂuoroquinolones and penicillins respectively. This is attributed to
inappropriate use of antimicrobials in humans and animals.
Methods & Materials: Desk review of recommendations made
inminutes and reports ofmeetings, conferences andworkshops on
Infection prevention and control and AMR and publications from
studies done in sentinel sites in Kenya.
Results: In 2009 the Global Antibiotic Resistance Partnership
Kenya was established. GARP-K completed and launched a Situa-
tion analysis(SA) of antibiotic use and resistance in Kenya in August
2011; In November 2013- Kenya hosted the ﬁrst Antimicrobial
Resistance (AMR) awareness week and a regional antibiotic stew-
ardship workshop in December 2013 whose recommendations
were submitted to the National Infection Prevention and Control
Committee (NIPCC) at the MOH in Kenya; Following this, ﬁndings
of the SA were disseminated to health managers in 45 counties in
Kenya, InMarch 2014 theNIPCC recommended the appointment of
an AMR focal point; Through the Infection Prevention and Control
Unit the National strategic plan for IPC with two strategic objec-
tives speciﬁc for AMR: establishing a national AMR Surveillance
system and the appointment of National Antimicrobial Steward-
ship Advisory Committee (NASAC);November 2014- during the 2nd
National AMR week the Director of Medical Services established
AMR program and appointed a multisectoral NASAC.
Conclusion: Low interest by leadership on AMR, lack of pri-
oritization and resource allocation by the Ministry of Health for
AMR related activities, changes in the system of governance in the
country following devolution further slowed down the process of
developing national strategies to ﬁght AMR
The AMR program through the leadership of NASAC is in the
process of developing a National Action Plan and policy for AMR
addressing recommendations in the SA and leveraging the inter-
national health regulations and the global health security agenda.
Through the AMR program, revision of the National IPC policy,
guidelines and IPC training curriculumhave included antimicrobial
resistance and antimicrobial stewardship.
http://dx.doi.org/10.1016/j.ijid.2016.02.301
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Antimicrobial use in children at a tertiary
teaching hospital in New Zealand
N. Ghoreishi1,∗, T. Graham2, L. McDermott3, S.
Gardiner3, T. walls2
1 Mashhad University of Medical Sciences, Mashhad,
Iran, Islamic Republic of
2 University of Otago, Christchurch, New Zealand
3 Christchurch Hospital, Christchurch, New Zealand
Background: Antimicrobials are one of the most common
medicines prescribed for children. We aimed to describe the
antimicrobial utilization in paediatric wards of a general teaching
hospital and to assess the compliance of this pattern using three
recently introduced guidelines: ChristchurchHospital local antimi-
crobial guideline, the Hospital Medicines List (HML – a national
list of available pharmaceuticals) restrictions and the New Zealand
National Formulary (NZF). The arrival of the Pharmaceutical Man-
agement Agency’s (PHARMAC) HML in July 2013 was the ﬁrst
introduction to a restrictive antimicrobial policy in New Zealand.
NZF provides antibacterial policies which may indicate a range of
drugs for general use, and permit other drugs only on the advice of
the microbiologist or paediatric infectious disease specialist.
Methods & Materials: We conducted a prospective cross-
sectional study of antimicrobial prescriptions over ten weeks
(Oct to Dec, 2013). The audit included all paediatric wards at
Christchurch Hospital, including medical and surgical patients and
inpatients in a national oncology centre. We identiﬁed all chil-
dren receiving antimicrobials and evaluated their prescription for
dosage accuracy, reason of administration, duration of treatment,
and compared these with both local and national guidelines.
Results: A total of 1000 antibiotic prescriptions were issued
for 41 different antibiotics. Overall, 24% (416 out of 1762) of the
children received at least one antibiotic agent during their hospi-
talization. The most commonly prescribed antibiotics were amox-
icillin/clavulanate, amoxicillin, trimethoprim/sulfamethoxazole,
